Biotech · Private company
LaNova Medicines Limited
Track this companyFree. Adds LaNova Medicines Limited to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- An Anti-PD-1 AntibodyPhase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- LM-108Phase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- LM-24C5Phase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- Drug：LM-102Phase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Study of LM-24C5 For Advanced Solid TumorsPHASE1_PHASE2 · RECRUITING · started Dec 20, 2023ClinicalTrials.gov NCT06187402 · fetched Nov 12, 2026
- Study of LM-108 as a Single Agent or in Combination With Pembrolizumab in Subjects With Advanced Solid TumoursPHASE1_PHASE2 · TERMINATED · started May 26, 2022ClinicalTrials.gov NCT05255484 · fetched Nov 12, 2026
- Study of LM-102 in Subjects in Advanced TumorsPHASE1 · TERMINATED · started May 27, 2021ClinicalTrials.gov NCT04735796 · fetched Nov 12, 2026